The U.S. biosimilars market is a fast approaching reality. However, much
uncertainty lies ahead, including the market potential as a function of
physician adoption of biosimilars. This panel discussion was conducted to
preview the thoughts and expectations of specialty physicians who would be
expected to be among the first customers of biosimilars, with the objective of
gaining insight into some of the major factors which could influence market
uptake. The research for this service was gathered from a panel consisting of
20 pre-selected specialty physicians and was conducted via online moderated
discussion boards over a three-day period. Key findings, qualitative analyses
and recommendations are included.
Table of Contents
Table of Contents
Executive Summary
Introduction
Physician Prescribing Behavior
Customer Purchasing Behavior
Regulatory Environment
Biosimilar Manufacturers
About Frost & Sullivan
Specialty Physicians Discuss their Opinions of the United States Biosimilars Market published by Frost & Sullivan in December 8, 2011. This report consists of 74 Pages and the price starts from US $ 10000.
